After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
CRISPR Therapeutics AG is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of CRISPR Therapeutics AG is $3.82B. A total of 3.06 million shares were traded on the day, compared to an average of 2.30M shares.
In the most recent transaction, Patel Naimish sold 3,932 shares of CRSP for 35.94 per share on May 29 ’25. After the transaction, the Chief Medical Officer now owns 6,068 company shares. In a previous transaction on Mar 21 ’25, Kulkarni Samarth sold 10,031 shares at 41.23 per share. CRSP shares that Chief Executive Officer owns now total 195,085.
Among the insiders who sold shares, Bruno Julianne disposed of 1,714 shares on Mar 21 ’25 at a per-share price of $41.23. This resulted in the Chief Operating Officer holding 10,544 shares of CRSP after the transaction. In another insider transaction, Prasad Raju sold 2,197 shares at $41.23 per share on Mar 21 ’25. Company shares held by the Chief Financial Officer now total 16,767.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CRSP has a high of $63.68 and a low of $30.04.
As of this writing, CRSP has an earnings estimate of -$1.46 per share for the current quarter. EPS was calculated based on a consensus of 18.0 estimates, with a high estimate of -$0.93 per share and a lower estimate of -$2.27.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRSP’s latest balance sheet shows that the firm has $2.38B in Cash & Short Term Investments as of fiscal 2021. There were $225.03M in debt and $119.88M in liabilities at the time. Its Book Value Per Share was $21.18, while its Total Shareholder’s Equity was $2.40B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
